Home » Topics » BioWorld Science

BioWorld Science
RSS

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

Feb. 1, 2022

Novel ester prodrugs of E-selectin antagonists with improved PK properties

Feb. 1, 2022

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Feb. 1, 2022

IDE-161 enters IND-enabling studies

Jan. 31, 2022

Improved retinal transplants ready for clinical trials

Jan. 31, 2022

Design of a next-generation cell-based therapy against diabetes

Jan. 31, 2022

ATH-434 demonstrates efficacy in preclinical multiple system atrophy

Jan. 31, 2022

STI-1558 strongly inhibits Omicron variant in cell-based assays

Jan. 31, 2022

New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding

Jan. 31, 2022

Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists

Jan. 31, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....